Telesis Bio Stock Market Value
| TBIO Stock | USD 0.05 0.00 0.00% |
| Symbol | Telesis |
Telesis Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telesis Bio's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telesis Bio.
| 12/15/2025 |
| 01/14/2026 |
If you would invest 0.00 in Telesis Bio on December 15, 2025 and sell it all today you would earn a total of 0.00 from holding Telesis Bio or generate 0.0% return on investment in Telesis Bio over 30 days. Telesis Bio is related to or competes with Cyduct Diagnostics, Escalon Medical, Mid Atlantic, and Epigenomics. Translate Bio, Inc., a clinical-stage messenger RNA therapeutics company, develops medicines to treat diseases caused by... More
Telesis Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telesis Bio's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telesis Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 67.42 | |||
| Information Ratio | 0.2035 | |||
| Maximum Drawdown | 824.84 | |||
| Value At Risk | (40.00) | |||
| Potential Upside | 284.62 |
Telesis Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Telesis Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telesis Bio's standard deviation. In reality, there are many statistical measures that can use Telesis Bio historical prices to predict the future Telesis Bio's volatility.| Risk Adjusted Performance | 0.1627 | |||
| Jensen Alpha | 23.09 | |||
| Total Risk Alpha | 12.13 | |||
| Sortino Ratio | 0.3911 | |||
| Treynor Ratio | 0.6515 |
Telesis Bio Backtested Returns
Telesis Bio is out of control given 3 months investment horizon. Telesis Bio owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.21, which indicates the firm had a 0.21 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-four different technical indicators, which can help you to evaluate if expected returns of 28.76% are justified by taking the suggested risk. Use Telesis Bio Semi Deviation of 18.8, coefficient of variation of 489.68, and Risk Adjusted Performance of 0.1627 to evaluate company specific risk that cannot be diversified away. Telesis Bio holds a performance score of 16 on a scale of zero to a hundred. The entity has a beta of 40.6, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Telesis Bio will likely underperform. Use Telesis Bio maximum drawdown, as well as the relationship between the expected short fall and day typical price , to analyze future returns on Telesis Bio.
Auto-correlation | 0.34 |
Below average predictability
Telesis Bio has below average predictability. Overlapping area represents the amount of predictability between Telesis Bio time series from 15th of December 2025 to 30th of December 2025 and 30th of December 2025 to 14th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telesis Bio price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Telesis Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | 0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Telesis Bio lagged returns against current returns
Autocorrelation, which is Telesis Bio pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Telesis Bio's pink sheet expected returns. We can calculate the autocorrelation of Telesis Bio returns to help us make a trade decision. For example, suppose you find that Telesis Bio has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Telesis Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Telesis Bio pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Telesis Bio pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Telesis Bio pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Telesis Bio Lagged Returns
When evaluating Telesis Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Telesis Bio pink sheet have on its future price. Telesis Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Telesis Bio autocorrelation shows the relationship between Telesis Bio pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Telesis Bio.
Regressed Prices |
| Timeline |
Other Information on Investing in Telesis Pink Sheet
Telesis Bio financial ratios help investors to determine whether Telesis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telesis with respect to the benefits of owning Telesis Bio security.